A child is taking azathioprine (Imuran) for moderate Crohn's ...

[haleyc112]

A child is taking azathioprine (Imuran) for moderate Crohn's disease. Which assessment finding best indicates that an important goal related to this medication has been met?
 
  A.
  The child has not developed seasonal illnesses.
  B.
  Edema and fluid retention have been eliminated.
  C.
  Stools are more solid and passed less often.
  D.
  Weight gain has been consistent at each visit.

Question 2

An adolescent is being treated with sulfasalazine (Azulfadine) for moderate Crohn's disease. How does the nurse explain the action of this medication to the patient?
 
  A.
  Causes immunosuppression
  B.
  Lessens diarrhea occurrences
  C.
  Reduces inflammation
  D.
  Treats crampy abdominal pain

[ngr69]

Answer to Question 1

ANS: A
Imuran is an immunosuppressive drug. Patients taking this medication (and others like it) are more prone to catching seasonal illnesses to which they are exposed in the community. A lack of such illnesses indicates that a goal for the diagnosis of risk for infection (important when using this drug) has been met. Weight gain would indicate better absorption of nutrients, which is a problem in Crohn's disease, but it is not most closely correlated to this drug. The other two options are not related to this drug.

Answer to Question 2

ANS: C
Sulfasalazine is a 5-aminosalicylic acid drug that reduces inflammation.